TRIUMEQ PD

ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE · ViiV Healthcare Company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TRIUMEQ PD, covering 2022-03-30 to 2024-04-18. Get the full timeline:

Most recent: FDA Approved: TRIUMEQ PD — Supplemental Application (ViiV Healthcare Company)